Suozzi will build on Medicare drug-price reforms by increasing the number of drugs Medicare can negotiate and extending savings to people with private insurance.

Tom knows that we need to build on these successes by increasing the number of drugs Medicare can negotiate and passing on the cost savings to people with private insurance as well.

Commits to further reduce prescription drug prices through expanded Medicare negotiation and broader savings.

Tom Suozzi's 10-Point Plan - Suozzi for Congress
campaign · campaign_site · model gpt-5.4-mini

Lower the Cost of Living, Repeal the SALT Cap, and Further Reduce Prescription Drug Prices

The plan commits to further reducing prescription drug prices.

Suozzi Unveils 10-Point Plan to Help Restore Sanity to Washington and Get Things Done - Suozzi for Congress
campaign · press_release · model gpt-5.4-mini

Tom knows that we need to build on these successes by increasing the number of drugs Medicare can negotiate and passing on the cost savings to people with private insurance as well.

Archived campaign material states the promise directly: expand Medicare negotiation and extend savings to private insurance.

never unknown

Tom Suozzi's 10-Point Plan - Suozzi for Congress
campaign · model gpt-5.4-mini · confidence 96%

To expand the drug price negotiation program under title XI of the Social Security Act and repeal certain changes to the program made by Public Law 119–21, to apply prescription drug inflation rebates under the Medicare program to drugs furnished in the commercial market, and to establish out-of-pocket limits on expenditures for prescription drugs under private health insurance.

Congress advanced a bill to extend Medicare drug-price reforms into commercial-market and private-insurance coverage, but it was introduced by other House Democrats and remained a bill, not enacted law.

never unknown A for effort

H.R. 6166 - Lowering Drug Costs for American Families Act | Congress.gov
secondary · model gpt-5.4-mini · confidence 91%

In August 2022, President Biden signed the Inflation Reduction Act of 2022 (P.L. 117-169) into law. For the first time, the law provides Medicare the ability to directly negotiate the prices of certain high expenditure, single source drugs without generic or biosimilar competition. CMS selected ten drugs covered under Medicare Part D for the first cycle of negotiations for initial price applicability year 2026.

The baseline reform already in force expanded Medicare negotiation, but only to the statutory extent in the IRA; it did not itself extend negotiated prices to private insurance.

partial same_term

Medicare Drug Price Negotiation Program: Negotiated Prices for Initial Price Applicability Year 2026 | CMS
secondary · model gpt-5.4-mini · confidence 95%

This bill expands the Medicare Drug Price Negotiation Program to include additional drugs and drugs that are covered under private insurance. It also extends certain rebate requirements for covered drugs under Medicare to drugs that are covered under private insurance.

A concrete legislative effort existed to broaden negotiated prices and rebates to private insurance, but the Congress.gov record shows it was only introduced and then referred to subcommittee.

never unknown A for effort

H.R. 4895 - Lowering Drug Costs for American Families Act | Congress.gov
secondary · model gpt-5.4-mini · confidence 89%